← Leaderboards
Robert Winchester
Columbia University Health Sciences
$7,903,822
Attributed
$10,515,698
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,515,698 · 9
By mechanism
R01$8,999,688 · 5
T32$741,678 · 1
U19$400,332 · 2
R21$374,000 · 1
Top collaborators
- Joan Marie Bathon5 shared
- Adam Mor3 shared
- Megan Sykes3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Kelli Stidham Hall$5,210,174
- Konstantina Alexandropoulos$10,152,343
- Alexander M Friedman$3,476,240
- Megan Sykes$56,546,810
- Dena Goffman$2,294,506
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocytePathway InteractionsMediatingPeptidesAntigensAutomobile DrivingCellsEventExhibitsImmuneInflammationPredispositionAutoimmune DiseasesInfiltrationInflammatoryPhenotypeTissuesMolecularInjuryInsightImmune SystemBloodHematopoietic Stem CellsAutoimmune Responses
Grant awards (31)
Thymic selection abnormalities in Type 1 Diabetes$763,729
R01 · FY2025 · AI
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events$715,543
R01 · FY2025 · AI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$184,580
T32 · FY2025 · AR
Thymic selection abnormalities in Type 1 Diabetes$763,729
R01 · FY2024 · AI
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events$737,672
R01 · FY2024 · AI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$137,882
T32 · FY2024 · AR
Thymic selection abnormalities in Type 1 Diabetes$763,729
R01 · FY2023 · AI
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events$737,672
R01 · FY2023 · AI
Multidisciplinary Training in Molecular and Translational Rheumatology Research$157,476
T32 · FY2023 · AR
Multidisciplinary Training in Molecular and Translational Rheumatology Research$168,565
T32 · FY2022 · AR
Multidisciplinary Training in Molecular and Translational Rheumatology Research$93,175
T32 · FY2021 · AR
Significance of Intrarenal T Cells in SLE Nephritis$392,352
R01 · FY2019 · DK · contact PI
Significance of Intrarenal T Cells in SLE Nephritis$392,352
R01 · FY2018 · DK · contact PI
Significance of Intrarenal T Cells in SLE Nephritis$375,658
R01 · FY2017 · DK · contact PI
Significance of Intrarenal T Cells in SLE Nephritis$415,689
R01 · FY2016 · DK · contact PI
An RA immune system derived from patient's stem cells$136,000
R21 · FY2014 · AR · contact PI
An RA immune system derived from patient's stem cells$238,000
R21 · FY2013 · AR · contact PI
Immunopathogenic features in calcific aortic stenosis$390,828
R01 · FY2009 · HL · contact PI
Immunopathogenic features in calcific aortic stenosis$390,828
R01 · FY2008 · HL · contact PI
Immunopathogenic features in calcific aortic stenosis$387,866
R01 · FY2007 · HL · contact PI
Prediction of Lupus Outcome by Gene Expression Patterns$389,657
R01 · FY2006 · AI · contact PI
Immunopathogenic features in calcific aortic stenosis$376,383
R01 · FY2006 · HL · contact PI
Prediction of Lupus Outcome by Gene Expression Patterns$399,035
R01 · FY2005 · AI
Prediction of Lupus Outcome by Gene Expression Patterns$402,591
R01 · FY2004 · AI
Prediction of Lupus Outcome by Gene Expression Patterns$204,375
R01 · FY2003 · AI
Core--Spectra typing/sequencing for TCR repertoire$0
U19 · FY2002 · AI
Antigen and nonantigen driven TCR repertoires in arthritis$0
U19 · FY2002 · AI
Core--Spectra typing/sequencing for TCR repertoire$0
U19 · FY2001 · AI
Antigen and nonantigen driven TCR repertoires in arthritis$0
U19 · FY2001 · AI
Core--Spectra typing/sequencing for TCR repertoire$200,166
U19 · FY2000 · AI
Antigen and nonantigen driven TCR repertoires in arthritis$200,166
U19 · FY2000 · AI